Tag: Lin Ching Yang
Firms act on Kelun-Biotech’s HKD1.9bn H-share placement
Zhong Lun, S&C, Kirkland & Ellis advised on Kelun-Biotech’s HKEX H-share placement raising HKD1.94b (USD250m)
Sullivan & Cromwell steers Saudi Arabian joint venture
Sullivan & Cromwell advised Foxconn Interconnect Technology on a USD100 million joint venture with Saudi Arabia’s Saleh Suleiman Alrajhi & Sons
Fangda, Sullivan & Cromwell act on XPeng buy of Didi’s EV unit
Fangda Partners and Sullivan & Cromwell have advised Chinese electric vehicle maker XPeng on its HKD5.84 billion (USD744 million) acquisition of Didi Global
Taiwanese company to buy ABB’s power conversion arm
Sullivan & Cromwell advised Taiwanese switching power supply manufacturer AcBel Polytech and Millbank represented Swedish-Swiss multinational ABB in the former’s acquisition of the latter’s US-based electricity conversion division for USD505 million
AIM Vaccine taps S&C and Jingtian on HKD156m listing on HKEX
China’s biggest privately owned vaccine group AIM Vaccine enlisted legal advice from Sullivan & Cromwell (S&C) and Jingtian & Gongcheng for its debut on the HKEX
LATEST ON LAW.ASIA
MOST READ ON LAW.ASIA
Pune Legal Market Guide
Experts share insights on why Pune is the right destination for establishing or expanding your business, and on the finer details of setting up
No flaws allowed
While stock exchanges lower barriers to atrract emerging sector issuers, regulators focus on accountability of listco and intermediaries at the top corporate level
